NanoViricides Inc. (NNVC)

[NNVClover]

Praying for ASAP. Of course INDs when it comes to 'bioterror' and diseases where you have a limited human population to study have different rules. Commonly cited is the "two species" rule. Of course any 'cide' for a mass market disease like HIV, Herpes, etc would have to go through a traditional IND process. Carcinogenicity, tox panels, ADME, the whole lot of it costs $1m+ if you want to do it fast. I have no idea where NNVC is in the process because they don't really talk about getting from point A to point B (rather, they focus on point B). I'll try to think about it a little more intelligently and get back to you.